GPCR – structure therapeutics inc. (US:NASDAQ)

News

Structure Therapeutics to Present Aleniglipron, Amylin and Combination Data at the American Diabetes Association 86th Scientific Sessions
Structure Therapeutics (GPCR) was given a new $101.00 price target by Canaccord Genuity Group Inc..
Structure Therapeutics (GPCR) had its "sell (d-)" rating reaffirmed by Weiss Ratings.
3 Ways to Invest in the Growing GLP-1 Weight Loss Market [Yahoo! Finance]
Structure Therapeutics (GPCR) was upgraded by Wall Street Zen from "s
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com